EC
ZURA icon

EntryPoint Capital’s Zura Bio ZURA Stock Holding History

EntryPoint Capital’s Portfolio ZURA Stock Details ZURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$170K Buy
+28,806
New +$137K 0.04% 713

Other funds holding ZURA

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

EntryPoint Capital's ZURA Position: Q2 2026 in Review

EntryPoint Capital opened a new position in Zura Bio (ZURA) in Q2 2026: 28,806 shares worth $170K. The stake represents 0.04% of the portfolio and ranks #713 among its holdings.

95 funds tracked by Wall St. Rank hold ZURA as of Q2 2026.

  • EntryPoint Capital held 28,806 shares of Zura Bio worth $170K as of Q2 2026.
  • Zura Bio was a new EntryPoint Capital position in Q2 2026.
  • Zura Bio made up 0.04% of EntryPoint Capital's portfolio in Q2 2026, its #713 holding.
  • 95 funds tracked by Wall St. Rank held Zura Bio as of Q2 2026.

Based on EntryPoint Capital's 13F filing for Q2 2026, filed 13 Aug 2026.